
Kutztown University gets state grant to support program that addresses teacher shortage
Yahoo is using AI to generate takeaways from this article. This means the info may not always match what's in the article. Reporting mistakes helps us improve the experience.
Yahoo is using AI to generate takeaways from this article. This means the info may not always match what's in the article. Reporting mistakes helps us improve the experience.
Yahoo is using AI to generate takeaways from this article. This means the info may not always match what's in the article. Reporting mistakes helps us improve the experience. Generate Key Takeaways
Kutztown University has been awarded a state grant to support a program that is helping to combat the ongoing teacher shortage in Pennsylvania.
The state Department of Education will provide $946,951 to KU through the department's dual credit innovation program. The money will support scholarships and programming for the school's Early College Academy for Education.
Through the academy, high school students with a general interest in working with children and education studies can attend classes on KU's campus, where they will take two courses in the fall semester and two in the spring. The four courses count toward majors in education.
The program is being piloted at KU, with 39 students taking part. The grant will allow the academy to expand to 60 students next school year.
The following year, the academy will serve an additional 30 in an off-site, rural school district cluster.
Classes are scheduled for half a day, two to three days a week. By the end of the academic year students will have earned 12 credits, which equals one semester.
The academy aims to boost the ranks of teachers, which have been dwindling for several years and took a major hit during the COVID-19 pandemic. According to a report by Penn State University's Center for Evaluation and Education Policy Analysis, 38% of school districts across the state reported at least one teacher vacancy this school year.
'The support of the Pennsylvania Dual Credit Innovation Grant will allow us to address the financial and transportation barriers to recruiting teachers,' Dr. Rebecca West Burns, dean of KU's college of education, said in a statement announcing the grant. 'Solving the teacher shortage in Pennsylvania requires a movement away from quick fix, Band-Aid approaches that fast-track preparation or ease the path to certification. Kutztown University is proud and incredibly appreciative of our strong partnerships with our local schools.
'Together, we aim to build a systemic pipeline that recruits high school students, prepares them through partnership in Kutztown's college of education's excellent programs and returns them to their school districts to teach.'
Anyone interest in the academy can contact Burns at burns@kutztown.edu or 610-683-4300. For more information about the academy, visit kutztown.edu/admissions/apply/first-year-students/early-college-academy.html.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
The US labor market is creating new jobs, but maybe not yours
Your own job is a binary event — you either have one or you don't. Labor market data so closely tracked by investors offers a different story about US employment, one told in the aggregate. And reconciling the two right now has made discussion about the overall state of the US job market particularly rich. In May, the US economy added 139,000 new jobs while the unemployment rate held steady at 4.2%. Data on job openings posted last week showed a surprise increase in April, though hiring demand continues to cool from post-pandemic highs. That's at least according to the US government. By subscribing, you are agreeing to Yahoo's Terms and Privacy Policy Data from payroll processor ADP published last week, however, suggested there were only 37,000 roles added to the private sector, the fewest since March 2023. For recent college grads and others at the entry level of the workforce, the job market hasn't been this challenging in years. Take this labor market data together with surveys from the services and manufacturing industries, and some economists see signs of "paralysis" forming in the US economy. As President Truman once said, it's a recession when your neighbor loses their job and a depression when you lose yours. A reimagining of this quote might say it's an economic expansion when your recent college graduate secures a job before being handed their diploma and a recession if they're still out of work when school starts again in the fall. In a modern labor market context where many thousands of people cobble together disparate income streams via consulting, contract work, influencing, and so forth, the lines around employment and unemployment might blur. Employment insurance data published weekly by the Department of Labor is less ambiguous. Though again, here we see enough room for two visions of the labor market to appear. On a weekly basis, initial filings for unemployment insurance remain low, tallying 247,000 last week. And though this was the most since October, economists at Barclays said in reaction to the report that the figures looked "exaggerated" due to a large increase from Kentucky and lingering seasonal adjustment issues related to the pandemic. Contrasting that are the continuing jobless claims — or the number of people who have filed for benefits after at least one week of unemployment — which have risen to nearly four-year highs in recent weeks. "The elevated level of continued claims is consistent with other data, like a low hiring rate and increasing duration of unemployment, indicating that it is difficult for those who are unemployed to find new jobs," Nancy Vanden Houten, lead US economist at Oxford Economics, wrote in a note last week. In May, the number of Americans unemployed for at least 15 weeks totaled 2.5 million; a year ago, this stood at 2.31 million. Some interpretations of the data offer close watchers scope to choose their own adventure through this shift in the labor market. But what's clear is that there has been a shift. And after many years of the labor market continuing to prove resilient, the risks are tilted toward ignoring a change in character and forgetting that while your own employment may have an on/off switch, the US economy is too big and plodding to turn at the speed of life. "The main risk is that the appearance of an okay labor market on the surface lulls the Federal Reserve into a false sense of security about the future," wrote Neil Dutta, head of economics at Renaissance Macro, in a note following Friday's monthly jobs report. "Labor market conditions are slowing down, and cyclical parts of the labor market continue to weaken."Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Portable Oxygen Concentrator Market is expected to double, reaching USD 4.5 billion by 2034
Portable Oxygenerator Market Outlook 2025–2034 Luton, Bedfordshire, United Kingdom, June 10, 2025 (GLOBE NEWSWIRE) -- Market Overview The global portable oxygenerator market is undergoing a period of sustained growth, with an estimated valuation of USD 2.1 billion in 2024. This market is forecasted to expand at a compound annual growth rate (CAGR) of approximately 8.0%, reaching USD 4.5 billion by 2034. The primary drivers of this growth include the increasing prevalence of chronic respiratory diseases such as COPD and asthma, an aging global population, and a rising inclination toward home-based healthcare solutions. Furthermore, technological progress and enhanced accessibility to oxygen therapy devices are transforming the dynamics of the market. Download PDF Brochure: Market Drivers A critical factor contributing to market expansion is the rising burden of respiratory ailments globally. As awareness around chronic lung conditions increases, so does the demand for dependable oxygen therapy equipment. This is especially pronounced among the elderly, who form a significant portion of the patient base requiring portable oxygen delivery systems. Another major driver is the technological evolution of oxygen concentrators. Modern portable oxygenerators are now smaller, lighter, and equipped with longer-lasting batteries, improving their usability for both domestic and mobile purposes. The integration of smart technologies, such as real-time oxygen level monitoring and remote data transmission, has enhanced the effectiveness and attractiveness of these devices. Additionally, healthcare reforms and infrastructure development, particularly in developing countries, are fostering broader adoption of oxygen therapy products. Governments and private players are making significant investments in health systems to accommodate the rising need for respiratory care, thereby opening new market opportunities. Market Restraints and Challenges Despite the optimistic outlook, several obstacles continue to hinder market acceleration. One of the foremost concerns is the high cost of advanced portable oxygenerators, which can deter uptake, especially in low-income or developing regions. While innovations are enhancing functionality, they also often raise the cost of manufacturing and final pricing. Regulatory complexities further impact the industry. Gaining approvals from regulatory bodies can be a time-consuming and expensive process. Moreover, companies face challenges related to distribution logistics, particularly in emerging markets where infrastructure and healthcare access remain limited. Global supply chain disruptions, amplified during the COVID-19 pandemic, revealed vulnerabilities in the procurement and distribution of essential components. Such uncertainties could result in delayed production timelines, reduced inventory levels, and higher operational risks. Segmentation Analysis By Product Type: Continuous Flow vs. Pulse Dose Oxygenerators Portable oxygenerators are broadly classified into continuous flow and pulse dose types. Continuous flow models, which deliver oxygen at a constant rate, dominate the market and are preferred in home care and clinical settings where steady oxygen supply is essential. On the other hand, pulse dose models, which dispense oxygen in bursts synchronized with the user's inhalation, are gaining popularity among mobile users and active individuals due to their energy efficiency and portability. By Technology: Molecular Sieves vs. Membrane Separation In terms of technology, molecular sieve systems lead the market. They are known for delivering high-purity oxygen and are widely adopted in hospital and home care applications. Conversely, membrane separation systems are less efficient but more cost-effective, making them suitable for budget-conscious or recreational applications. Continuous research and development in improving the efficiency and affordability of molecular sieves signal strong growth prospects for this segment. By Application: Medical, Industrial, and Recreational The medical segment remains the dominant application category, accounting for the highest revenue share. This is driven by the clinical need for continuous oxygen therapy among patients with chronic respiratory disorders. However, recreational and industrial applications are emerging steadily. Recreational use, especially in sports and high-altitude activities, is on the rise. In the industrial sector, portable oxygen systems are utilized in manufacturing, welding, and chemical processing, where reliable oxygen delivery in remote environments is crucial. By End-User: Hospitals, Home Care, Emergency Services, and Sports & Fitness Hospitals form the largest user segment, owing to their critical need for oxygen during surgeries, intensive care, and emergency treatments. The home care segment is also expanding rapidly due to the aging population and a societal shift toward home-based healthcare. Meanwhile, emergency services and sports & fitness represent emerging niches. Emergency responders are increasingly adopting portable systems for their ability to provide immediate oxygen in critical scenarios. The sports and fitness segment is attracting attention as athletes and health-conscious individuals explore oxygen therapy for enhanced recovery and performance. By Distribution Channel: Online and Offline Distribution is evolving with the growing importance of online retail channels, especially post-pandemic. Online platforms offer wider reach, consumer education, and price transparency, making them a preferred option for many users. Nevertheless, offline distribution through pharmacies, medical equipment stores, and hospital networks still holds substantial market share, especially in regions where e-commerce penetration remains limited. Market Segmentation Product Type Continuous Flow Oxygenerators Pulse Dose Oxygenerators Technology Molecular Sieves Membrane Separation End-User Hospitals Home Care Emergency Services Sports and Fitness Distribution Channel Online Distribution Offline Distribution Application Medical Recreational Industrial Browse full Report - Regional Insights North America North America leads the global portable oxygenerator market, capturing around 40% of the total revenue in 2024. This is attributed to the presence of advanced healthcare infrastructure, high prevalence of respiratory conditions, and proactive government policies promoting home healthcare. Technological innovation and consumer awareness are also more mature in this region. Europe Europe holds a significant share of approximately 30%, fueled by increasing awareness around oxygen therapy, a rising elderly population, and favorable reimbursement policies. The European market is expected to grow at a CAGR of about 5% through 2034. Asia-Pacific The Asia-Pacific region is witnessing rapid market expansion, with a projected CAGR of 7%. Key drivers include rising air pollution, increasing healthcare investments, and a large patient population base. Countries like China, India, and Japan are driving demand through both public and private sector healthcare initiatives. Latin America, Middle East, and Africa Emerging markets in Latin America and the Middle East & Africa offer considerable growth opportunities. Challenges such as limited infrastructure and inconsistent regulations exist, but these are gradually being addressed through public-private partnerships and increasing medical awareness. Cost-effective product offerings tailored for local needs could unlock growth in these regions. Competitive Landscape The competitive environment is characterized by innovation, partnerships, and geographical expansion. Key players in the industry include: Philips Respironics Inogen, Inc. AirSep Corporation ResMed Chart Industries DeVilbiss Healthcare Caire Inc. Oxymat A/S Invacare Corporation Companies are increasingly investing in product development and acquisitions to enhance their market position. Strategic alliances with local distributors are also being leveraged to improve regional penetration. Recent Market Developments Philips Respironics launched the SimplyGo Mini+ in January 2023, featuring longer battery life and improved mobility, addressing user demand for highly portable medical-grade solutions. In March 2023, Inogen, Inc. acquired a technology firm specializing in oxygen delivery innovation, aiming to boost its technological edge and expand its product line. ResMed, in July 2023, announced its expansion into the Asia-Pacific market, targeting India and Southeast Asia to capitalize on increasing demand and investment in healthcare. AirSep Corporation introduced a new portable oxygen concentrator in September 2023 with reduced power consumption and enhanced oxygen purity, appealing to cost-conscious and eco-friendly buyers. Chart Industries entered a strategic partnership in India in October 2023 to expand its distribution network and cater to rising local demand. This report is also available in the following languages : Japanese (ポータブル酸素発生器市場), Korean (휴대용 산소 발생기 시장), Chinese (便携式制氧机市场), French (Marché des oxygénateurs portables), German (Markt für tragbare Sauerstoffgeneratoren), and Italian (Mercato degli ossigeneratori portatili), etc. Request Sample Pages: More Research Finding – Indoleamine 2,3 Dioxygenase 1 IDO1 ELISA Kit Market The market for Indoleamine 2,3 Dioxygenase 1 (IDO1) ELISA kits is poised for significant growth, with a current estimated value of approximately USD 150 million in 2024. This market is projected to reach around USD 300 million by 2034, reflecting increasing interest in immunotherapy and its applications in cancer treatment and autoimmune disorders. The anticipated CAGR for the period 2025–2034 is approximately 7%. Indoleamine 2,3 Dioxygenase 1 Antibody Market The Indoleamine 2,3 Dioxygenase 1 (IDO1) antibody market is poised for significant growth, projected to reach a value of approximately $1.2 billion in 2024. The market is expected to expand at a Compound Annual Growth Rate (CAGR) of 15% from 2025 to 2034, potentially reaching around $5.0 billion by the end of the forecast period. Obesity Hypoventilation Syndrome Treatment Market The Obesity Hypoventilation Syndrome (OHS) treatment market is projected to reach a value of approximately $1.2 billion in 2024 and is expected to grow significantly, with a forecasted market value of around $2.5 billion by 2034. This growth represents a Compound Annual Growth Rate (CAGR) of approximately 7.6% during the forecast period from 2025 to 2034. Medical Gas Making Equipment Market The global medical gas making equipment market is valued at approximately $1.2 billion, driven by the rising demand for medical gases in hospitals and the growth of home healthcare services. The projected market value is expected to reach around $2.3 billion by 2034, reflecting robust growth opportunities in emerging markets and innovations in technology. Hospital Centralized Oxygen Supply System Market The global market for Hospital Centralized Oxygen Supply Systems is valued at approximately $2.5 billion, with expectations to reach about $4.8 billion by 2034. This growth trajectory indicates a strong Compound Annual Growth Rate (CAGR) of around 7.2% during the forecast period of 2025–2034. Portable Oxygenerator Market The global portable oxygenerator market is valued at approximately USD 2.1 billion in 2024 and is projected to reach around USD 4.5 billion by 2034, reflecting a robust CAGR of about 8.0% during the forecast period from 2025 to 2034. Physical & Chemical Sensors for Water Market The global market for physical and chemical sensors for water is projected to reach approximately $5.2 billion in 2024, fueled by increasing concerns over water quality and pollution management. The market is expected to expand significantly, with a projected value of $9.1 billion by 2034, reflecting a robust Compound Annual Growth Rate (CAGR) of 5.5% during the forecast period from 2025 to 2034. Chemical Oxygen Demand COD Analyzers Market The global market for Chemical Oxygen Demand (COD) analyzers is valued at approximately $300 million in 2024. With increasing regulatory pressure for water quality monitoring and enhanced environmental protection standards, the market is projected to reach around $500 million by 2034. This represents a Compound Annual Growth Rate (CAGR) of about 5.2% during the forecast period from 2025 to 2034. Steel Wire Rod Market The global steel wire rod market is projected to be valued at approximately $150 billion in 2024, with expectations to reach around $220 billion by 2034. This growth reflects a Compound Annual Growth Rate (CAGR) of 4.0% during the forecast period of 2025 to 2034. Therapeutic Respiratory Devices Market The global market for therapeutic respiratory devices is estimated to reach approximately $31 billion in 2024, driven by increasing prevalence of respiratory diseases and rising healthcare expenditure. The market is projected to grow at a compound annual growth rate (CAGR) of around 7% from 2025 to 2034, anticipating a value of nearly $63 billion by the end of the forecast period. Cryogenic Submerged Electric Motor Pump Market The global market for cryogenic submerged electric motor pump systems is projected to be valued at approximately $2.1 billion in 2024, with expectations of reaching around $3.9 billion by 2034. This growth represents a Compound Annual Growth Rate (CAGR) of about 6.5% during the forecast period of 2025 to 2034. Extracorporeal Membrane Oxygenation ECMO Service Market The global Extracorporeal Membrane Oxygenation (ECMO) market is anticipated to reach a value of approximately $3.2 billion in 2024, driven by increasing prevalence of respiratory and cardiac illnesses, advancements in ECMO technologies, and a growing aging population. From 2025 to 2034, the market is projected to expand significantly, reaching an estimated $5.8 billion, reflecting a robust Compound Annual Growth Rate (CAGR) of around 7.2%. Oxygen Supply System to Hospitals Market the global oxygen supply system market for hospitals is valued at approximately $5.2 billion, reflecting a robust demand amid ongoing health challenges. The market is projected to reach about $8.4 billion by 2034, indicating significant growth over the next decade. This results in a Compound Annual Growth Rate (CAGR) of around 4.7% from 2025 to 2034. SBQ Steel Market The global Special Bar Quality (SBQ) steel market is valued at approximately $20 billion, with expectations of reaching $30 billion by 2034. This growth is projected at a compound annual growth rate (CAGR) of around 5.5% during the forecast period from 2025 to 2034. The market is currently characterized by robust demand across various sectors, particularly automotive and construction, driven by the rising need for high-strength materials. High Purity Oxygen Market The global high purity oxygen market was valued at approximately $6.2 billion in 2024, driven by applications in healthcare, steel manufacturing, and electronics. With increasing demand for high-purity oxygen in medical applications, particularly in respiratory therapies amid rising respiratory diseases, the market is poised for significant growth. The projected market value is expected to reach around $10.5 billion by 2034, indicating a robust expansion trajectory. CONTACT: Irfan Tamboli (Head of Sales) Phone: + 1704 266 3234 Email: sales@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
OPINION - The City wanted Labour to succeed, but the goodwill has been rapidly squandered
In April 2024 the boardrooms in the City of London and some from industry and commerce were buzzing with excitement at the prospect of Labour taking over from a rudderless Conservative administration. In the previous four years, the Tory government never recovered from the damage inflicted by Covid, coupled with indolent leadership from three Prime Ministers in double quick time. This was Labour's time. The mood was upbeat. 'Fear initially knocked at the door, faith answered; no one was there.' The smoked salmon bagel breakfasts hosted for combinations from Messrs Starmer, Reeves, Reynolds and Siddiq were very encouraging. The PM in waiting and his colleagues had charmingly reassured their board table hosts that Labour was the party for business and growth. Business had nothing to worry about. Labour was very much 'on-side' and knew unequivocally that to achieve growth, incentives to invest must be encouraged. All Labour's ducks seemed to be set up cleverly in a row. It took only six months for the reassured to start having considerable doubts, such was the damage inflicted on business by an increase on employers' share of National Insurance Contributions. There were also very little in the way of incentives to encourage inward investment, despite the formation of the National Wealth Fund and the British Business Bank to support Labour's ambitious plans for massive infrastructure projects. Confidence in the new government started to fall like a stone. Global investors seemed very reluctant to support some of our aspiring SMES, especially the fin-tech operations. Many market activists have blamed Brexit, which had only been delivered in name only. What was so frustrating was the ineptness of the Conservatives, which failed to deliver a gold-plated certainty – the increased prosperity of the 'City' – the quintessential cash cow. The financial sector in the UK was already delivering £75 billion of revenue per annum to the HM Treasury's coffers and there could have been so much more to come. The previous Government failed to capitalise on the value of the City. Brexit should have been a 'slam-dunk' for the City. Sadly, no exciting tax incentives for companies to set up in the UK were put into place. Regulation was far too onerous and cumbersome. Also, if the UK aspired to be the world's leading financial centre, charging stamp duty on trading shares was unrealistic financial nonsense. Also spiteful legislation towards 'non-doms' just exacerbates the negative perception of the UK's ability to create growth. The '80's were the halcyon years for the City, triggered by the abolition of exchange controls in 1979, followed up in 1986 by 'Big Bang', which saw international investment banks such as Goldman Sachs, JP Morgan, Deutsche Bank and UBS rub shoulders and then usurp many of the grand old merchant banks of the day such as SG Warburg, Morgan Grenfell, Schroders, Samuel Montagu and Barclays Capital. The introduction of the LIFFE futures market in 1984 and the explosion of derivative trading triggered the expansion of capital markets and a tsunami of IPOS and privatisations. London still remains a major financial hub. However, there is some alarming unappetising data to reckon with. In 2007, the UK had 252 Initial Public Offerings (IPOs) on the London Stock Exchange. This represented a decrease from the 367 IPOs the previous year, with overseas IPOs attracted 86 companies from 22 countries. Last year was a poor year for IPOS, mainly due to a dip in confidence and geopolitical issues – just 17 in total here in London and 18 so far this year. There have been 58 IPOS in New York since January 2025. What is very worrying is that in the last year 88 companies have delisted in London. The delisting started with ARM, which left London supposedly valued at $32 billion, is now valued at $138 billion! Flutter and DarkTrace - fallen to US private equity- plus many others have followed. It is generally acknowledged that US fund managers have access to many more investors and consequently greater liquidity has contributed to a 25% valuation premium there. A lack of confidence and enthusiasm in the UK economy have encouraged moves to New York. Recently, Revolut served notice to establish a new Western Europe HQ in Paris and earlier last week 'Wise' said it will be delisting in London and heading for New York. It is alarming to note that only 4% of the LSE'S annual income is derived from stock exchange business. The rest comes from technology (Refinitiv). The LSE needs to raise its game, as does AIM. Aquis Exchange have hosted 4 IPOS so far this year and the outlook, under fresh ownership of 'Six' looks encouraging. Monzo, Starling Bank, Virgin Atlantic, ASDA and Boots are in the mix of companies that may seek public quotations this year, but much depends on market conditions. Hong Kong's Shein's IPO remains in doubt. If the Government believes in growth, then its emissaries, Business Secretary Jonathan Reynolds, Economc Secretary Emma Reynolds and investment minister Baroness Poppy Gustafsson need to wake up and smell the coffee? Business's risk appetite is at a low ebb. Confidence and sentiment are stagnant. Investors are vital. They must be encouraged with incentives! Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data